Health Care

Middle-market dealmakers say the pace of growth in overall deal flow increased again in July.

After a brief hiatus in April and May, U.S. IPOs are making a comeback, with this week set to be the biggest since 2006, according to Renaissance Capital data.

Merck agreed to sell Asian rights to its eye treatment products business to Japan’s Santen Pharmaceutical for $600 million. 

The Botox maker turned down an unsolicited $46 billion bid from Valeant Pharmaceuticals, which vowed to continue its pursuit of a deal.

CVS Health and Target ink deal for CVS to acquire Target's pharmacy and clinic businesses for about $1.9 billion.

Many athletes follow a pretty standard routine. Hit the gym, grab a protein shake, repeat. Others, like surfer Laird Hamilton, take fitness to another level. Hamilton and fitness expert Mike Barwis share some of their secrets.

As the biotech index soars to historic highs, industry investors are seeing gains of 50% in the past year. But while some investors are cashing in on medical breakthroughs, others are issuing a warning. Will we continue to see robust sector growth or will this boom come down crashing?

Once you reach that golden age of 65 Medicare steps in to take care of most of your healthcare needs.  But there are a lot of exclusions with Medicare plans and for Baby Boomers living on a fixed income, those exclusions along with the out of pocket expenses can have a huge impact on your financial future.

Wired medicine is becoming the way of the world as more doctors and pharmacists treat patients using the power of the internet. 

Herbalife threw a jab at Bill Ackman as the hedge fund manager and Valeant Pharmaceuticals investor mounted a defense of the drug company.

A front-page WSJ expose casts serious doubt on the efficacy and accuracy of Theranos’ purportedly disruptive blood testing technology.

The recently-enacted 2016 budget act took away some popular Social Security claiming strategies but it gave seniors a reprieve from as much as a 50% increase in their Medicare Part B premiums next year.

Infamous price gouging CEO Martin Shkreli was released on $5 million bond Thursday after being arrested on fraud charges. 

Public Citizen sent a letter to the drug promotion overseer at the Food and Drug Administration urging it to pull ads for five Type 2 diabetes drugs because it claims the ads promote benefits that have not been approved by the agency.

Merck & Co Inc is in talks to acquire Cubist Pharmaceuticals Inc for more than $7 billion in a deal that could be announced as early as next week, the New York Times reported on Friday, citing people briefed on the matter.

Electronic cigarettes may be more tempting to non-smoking youths than conventional cigarettes, a CDC study released Monday shows.

Shares in drugmaker AstraZeneca have climbed more than 7 percent this week, fueled by speculation of renewed takeover interest from Pfizer, following an abortive $118 billion (71 billion pounds) takeover attempt in May.

The U.S. drugmaker Pfizer is under fire on both sides of the Atlantic as it weighs its next move to buy British rival AstraZeneca.